What's in Shanghai Hutchison Pharmaceuticals Limited's pipeline?

Shanghai Hutchison Pharmaceuticals Limited has 3 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Shanghai Hutchison Pharmaceuticals Limited's portfolio?

Top competitors by shared drug class: Sanofi, ASLAN Pharmaceuticals, Ahn-Gook Pharmaceuticals Co.,Ltd, AbbVie, Aclaris Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shanghai-hutchison-pharmaceuticals-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Shanghai Hutchison Pharmaceuticals Limited — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shanghai Hutchison Pharmaceuticals Limited pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
MUSK pill	MUSK pill	marketed	Anticholinergic	M1 muscarinic receptor	Ophthalmology
SHPL-49 Injection	SHPL-49 Injection	phase 3	PD-1 inhibitor	PD-1	Oncology
Shenqi Sherong Pill	Shenqi Sherong Pill	phase 3			Traditional Chinese Medicine

Therapeutic area mix

Oncology · 1
Ophthalmology · 1
Traditional Chinese Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Sanofi · 2 shared drug classes
ASLAN Pharmaceuticals · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
AbbVie · 1 shared drug class
Aclaris Therapeutics, Inc. · 1 shared drug class
Addpharma Inc. · 1 shared drug class
ATGC Co., Ltd. · 1 shared drug class
3D Medicines (Sichuan) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shanghai Hutchison Pharmaceuticals Limited:

Cite this brief

Drug Landscape (2026). Shanghai Hutchison Pharmaceuticals Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shanghai-hutchison-pharmaceuticals-limited. Accessed 2026-05-17.